105 related articles for article (PubMed ID: 20107711)
1. [Compulsory licensing of efavirenz in Brazil in 2007: contextualization].
Rodrigues WC; Soler O
Rev Panam Salud Publica; 2009 Dec; 26(6):553-9. PubMed ID: 20107711
[TBL] [Abstract][Full Text] [Related]
2. Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.
Ford N; Wilson D; Costa Chaves G; Lotrowska M; Kijtiwatchakul K
AIDS; 2007 Jul; 21 Suppl 4():S21-9. PubMed ID: 17620749
[TBL] [Abstract][Full Text] [Related]
3. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
Rosenberg ST
Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542
[TBL] [Abstract][Full Text] [Related]
4. Initiatives to challenge patent barriers and their relationship with the price of medicines procured by the Brazilian Unified National Health System.
Scopel CT; Chaves GC
Cad Saude Publica; 2016 Dec; 32(11):e00113815. PubMed ID: 27925025
[TBL] [Abstract][Full Text] [Related]
5. An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
Jain D; Darrow JJ
Health Matrix Clevel; 2013; 23(2):425-57. PubMed ID: 24341078
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Usefulness of Compulsory Licensing in Developing Countries: A Comparative Study of Thai and Brazilian Experiences Regarding Access to Aids Treatments.
Guennif S
Dev World Bioeth; 2017 Aug; 17(2):90-99. PubMed ID: 27699996
[TBL] [Abstract][Full Text] [Related]
7. Patent litigation in India continues to throw up new challenges.
Reddy Thikkavarapu P
Pharm Pat Anal; 2016 Jul; 5(4):211-6. PubMed ID: 27348790
[TBL] [Abstract][Full Text] [Related]
8. Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union:
't Hoen EFM; Boulet P; Baker BK
J Pharm Policy Pract; 2017; 10():19. PubMed ID: 28670455
[TBL] [Abstract][Full Text] [Related]
9. US files WTO complaints against Brazil over requirement for "local working" of patents.
Elliott R
Can HIV AIDS Policy Law Rev; 2000; 5(4):28. PubMed ID: 11833162
[TBL] [Abstract][Full Text] [Related]
10. Compulsory pharmaceutical patent licensing in Brazil: the controversy of public interest.
Rodrigues da Silva C; Galvão de Botton L
Pharm Pat Anal; 2013 Nov; 2(6):685-7. PubMed ID: 24237232
[No Abstract] [Full Text] [Related]
11. Making tenofovir accessible in the brazilian public health system: patent conflicts and generic production.
Veras J
Dev World Bioeth; 2014 Aug; 14(2):92-100. PubMed ID: 24889312
[TBL] [Abstract][Full Text] [Related]
12. Compulsory licensing of patents in India.
Chaudhry R
Pharm Pat Anal; 2016 Sep; 5(6):401-406. PubMed ID: 27805847
[TBL] [Abstract][Full Text] [Related]
13. Learning from practice: compulsory licensing cases and access to medicines.
Stirner B; Thangaraj H
Pharm Pat Anal; 2013 Mar; 2(2):195-213. PubMed ID: 24237026
[TBL] [Abstract][Full Text] [Related]
14. Brazil's AIDS controversy: antiretroviral drugs, breaking patents, and compulsory licensing.
Marques UR; Guimarães VS; Sternberg C
Food Drug Law J; 2005; 60(3):471-7. PubMed ID: 16304752
[No Abstract] [Full Text] [Related]
15. Thailand and the compulsory licensing of efavirenz.
Steinbrook R
N Engl J Med; 2007 Feb; 356(6):544-6. PubMed ID: 17287474
[No Abstract] [Full Text] [Related]
16. The Brazilian experiment: HIV drugs for all.
Flaer PJ; Younis MZ
J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
[TBL] [Abstract][Full Text] [Related]
17. Compulsory licensing of patents.
Kumutha N; Amutha N; Venkatesh GS
Pharm Pat Anal; 2022 Nov; 11(6):225-231. PubMed ID: 36802922
[TBL] [Abstract][Full Text] [Related]
18. The Legislative Approach and System Improvement of China's Compulsory Licensing for Drug Patents.
Cao Z; Chen Y; Jiang W; Li W
Drug Des Devel Ther; 2021; 15():3717-3731. PubMed ID: 34511881
[TBL] [Abstract][Full Text] [Related]
19. The consumer welfare implications of governmental policies and firm strategy in markets for medicines.
Chatterjee C; Kubo K; Pingali V
J Health Econ; 2015 Dec; 44():255-73. PubMed ID: 26581076
[TBL] [Abstract][Full Text] [Related]
20. Drug policy and administration affecting quality of life of the poor in Thailand.
Prutipinyo C; Sirichotiratana N
Med Law; 2011 Sep; 30(3):311-22. PubMed ID: 22191322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
